Revenue Breakdown
Composition ()
No data
Revenue Streams
Retractable Technologies Inc (RVP) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Syringes, accounting for 58.0% of total sales, equivalent to $5.85M. Other significant revenue streams include EasyPoint Needles and Blood Cllection Products. Understanding this composition is critical for investors evaluating how RVP navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Retractable Technologies Inc maintains a gross margin of 16.72%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -21.20%, while the net margin is 3.68%. These profitability ratios, combined with a Return on Equity (ROE) of -8.36%, provide a clear picture of how effectively RVP converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, RVP competes directly with industry leaders such as MLSS and ADGM. With a market capitalization of $20.57M, it holds a significant position in the sector. When comparing efficiency, RVP's gross margin of 16.72% stands against MLSS's 68.67% and ADGM's N/A. Such benchmarking helps identify whether Retractable Technologies Inc is trading at a premium or discount relative to its financial performance.
